Skip to main content

Profile hero

Profile details

About Dr. Michael Ramb

Michael is a partner in our global regulatory practice.

He has extensive experience solving the regulatory challenges that arise in the context of cross-border corporate M&A transactions, carve-outs and re-structuring projects, including with respect to permits and licenses, environmental liabilities and product-related registrations. He advises both financial investors and strategic clients regarding a wide range of industry sectors, primarily healthcare, consumer products, chemicals, oil and gas, energy, aviation and general industries. This includes advising clients on the strategic management of regulatory risks and environmental liabilities in large-scale industrial and infrastructure projects such as industrial parks.

Michael also specialises in advising on regulatory product risks and crisis management, primarily in the pharmaceuticals, medical device, food, consumer goods, and chemicals sectors. As well as keeping clients up to speed on the latest regulatory requirements for the production, labelling and distribution of products, he advises on global market access projects, supply-chain compliance, cross-border product recalls, regulatory supervision, product liability and new challenges resulting from the increasing digitalisation of previously unconnected products.

He has substantial experience in anti-bribery and corruption compliance, advising companies on cross-border investigations and the implementation of compliance management systems, with a particular focus on the healthcare sector.

Recent work

  • Advising Merck KGaA on the sale of its global consumer health business to Procter & Gamble.
  • Advising EQT on the sale of BSN medical to SCA, and on the merger of Sivantos and Widex to create global No 3 in hearing aids.
  • Advising Mars Group on regulatory issues regarding the acquisition of Anicura, the pan-European vet clinic chain from Nordic Capital.
  • Advising Carlyle Group regarding the acquisition of Atotech (speciality chemicals) from Total.
  • Advising various multinational healthcare businesses regarding healthcare compliance and anti-bribery issues, internal investigations regarding cooperations with healthcare professionals and the implementation of global compliance management systems.



  • Universities of Bonn, Germany and Bristol, UK (law)
  • Nottingham Law School, UK (postgraduate diploma in environmental, planning and regulatory law)
  • University of Rostock, Germany (doctorate in law)


  • International Comparative Legal Guides Environment & Climate Change Law – Germany (with Wolf Spieth)

  • Regular workshops for the management, legal departments and employees of healthcare companies, 2014 to present Healthcare compliance in practice

  • Client briefing for our global healthcare and global financial investor clients, 2016 Germany introduces new criminal sanctions for bribery in the healthcare sector

  • CCZ - Corporate Compliance, 06/2015, S. 262 Healthcare Compliance: Aktuelle Entwicklungen und globale Trends

  • Compliance Berater, 3/2015, 72 Verschärfung des Korruptionsstrafrechts im Gesundheitssektor (with Laura Reich)